共 50 条
- [11] Severity of rheumatoid arthritis in Portuguese patients: comment on the article by Drosos et al and on the letter by Ronda et al - Reply ARTHRITIS AND RHEUMATISM, 2000, 43 (02): : 471 - 472
- [12] Anticitrulline antibody assay specificity for rheumatoid arthritis: comment on the article by Schellekens et al - Reply ARTHRITIS AND RHEUMATISM, 2000, 43 (08): : 1902 - 1902
- [13] Diagnostic value of Doppler ultrasonography in rheumatoid arthritis: comment on the article by Weidekamm et al - Reply ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 677 - 678
- [14] Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1782 - 1782
- [16] Is the "lipid paradox" in rheumatoid arthritis really a paradox? Comment on the article by Bartels et al Reply ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3645 - 3646
- [17] The heart in rheumatoid arthritis: contrasting or misleading data from clinical research? Comment on the article by Giles et al Reply ARTHRITIS AND RHEUMATISM, 2010, 62 (12): : 3834 - 3835
- [18] Incidence of vasculitis in rheumatoid arthritis:: comment on the article by Turesson et al ARTHRITIS AND RHEUMATISM, 2005, 52 (05): : 1620 - 1620
- [20] Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al Reply ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2826 - 2828